NasdaqGS - Nasdaq Real Time Price • USD
Compare
As of 1:38 PM EDT. Market Open.
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Ms. Suzanne Winter M.B.A. | President, CEO & Director | 1.02M | -- | 1963 |
Mr. Ali Pervaiz | Senior VP & CFO, Interim Principal Accounting officer | 601.12k | -- | 1981 |
Mr. Michael Hoge | Senior Vice President of Global Operations | 540.12k | -- | 1967 |
Mr. Jesse Chew | Senior VP, Chief Legal Officer & Company Secretary | 621.2k | -- | 1981 |
Mr. Sandeep Chalke | Senior VP & Chief Commercial Officer | 826.18k | -- | 1966 |
Mr. John M. Dunn | Vice President, Chief Information & Security Officer | -- | -- | -- |
Beth Kaplan | Public Relations Director | -- | -- | -- |
Ms. Melanie Gebauer | Vice President of Global Human Resources | -- | -- | -- |
Mr. Juki Hozumi | President & GM of Japan Region | -- | -- | -- |
Mr. Jim Dennison | Senior Vice President of Global Regulatory, Quality & Product Development | -- | -- | -- |
Accuray Incorporated
1240 Deming Way
Madison, WI 53717-1954
United States
608 824 2800 https://www.accuray.com
- Sector:
- Healthcare
- Industry:
- Full Time Employees:
- 1,024
Medical Devices
Description
Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, China, and rest of the Asia Pacific region. It offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. The company also provides the TomoTherapy System, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems. In addition, it offers post-contract customer support, installation, training, and other professional services. The company primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.
Corporate Governance
Accuray Incorporated’s ISS Governance QualityScore as of June 1, 2024 is 3. The pillar scores are Audit: 5; Board: 1; Shareholder Rights: 5; Compensation: 3.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
August 7, 2024 at 10:59 AM UTC - August 12, 2024 at 12:00 PM UTC
Accuray Incorporated Earnings Date
Recent Events
June 5, 2024 at 11:30 AM UTC
at Jefferies Heathcare Conference
May 31, 2024 at 12:00 AM UTC
SD: Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)
See Full Filing
May 10, 2024 at 12:00 AM UTC
8-K: Corporate Changes & Voting Matters
See Full Filing
May 8, 2024 at 12:00 AM UTC
10-Q: Periodic Financial Reports
See Full Filing
May 1, 2024 at 12:00 AM UTC
8-K: Corporate Changes & Voting Matters
See Full Filing
March 12, 2024 at 2:00 PM UTC
at Oppenheimer Healthcare MedTech & Services Conference (Virtual)
February 7, 2024 at 12:00 AM UTC
10-Q: Periodic Financial Reports
See Full Filing
January 31, 2024 at 12:00 AM UTC
8-K: Corporate Changes & Voting Matters
See Full Filing
January 25, 2024 at 12:00 AM UTC
SC 13G: Tender Offer/Acquisition Reports
See Full Filing
Related Tickers
APYX Apyx Medical Corporation
1.3325
-2.02%
ATEC Alphatec Holdings, Inc.
10.34
-0.39%
CUTR Cutera, Inc.
1.6150
-0.92%
OFIX Orthofix Medical Inc.
12.61
-2.02%
CNMD CONMED Corporation
66.99
-0.73%
CTSO Cytosorbents Corporation
0.8398
+11.53%
SRTS Sensus Healthcare, Inc.
5.11
-0.97%
PAVM PAVmed Inc.
0.8600
-7.03%
CATX Perspective Therapeutics, Inc.
10.63
-10.90%
AMIX Autonomix Medical, Inc.
1.1200
0.00%